Clinicians versus patients subjective adverse events assessment: based on patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)

[1] Basch E(2010)The missing patient voice in drug-safety reporting New England Journal of Medicine 362 865-317

[2] Basch E(2014)New frontiers in patient-reported outcomes: Adverse event reporting, comparative effectiveness, and quality assessment Annual Review of Medicine 65 307-1149

[3] Ebile AW(2015)Assessing the detection, reporting and investigation of adverse events in clinical trial protocols implemented in Cameroon: A documentary review of clinical trial protocols BMC Medical Ethics 16 67-196

[4] Ateudjieu J(2013)Patient-reported outcome measures in safety event reporting: PROSPER Consortium guidance Drug Safe 36 1129-87

[5] Yakum MN(2014)Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) Journal of the National Cancer Institute 106 dju244-4255

[6] Djuidje MN(1977)The measurement of observer agreement for categorical data Biometrics 33 189-1052

[7] Watcho P(2016)A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department International Journal of Clinical Pharmacy 38 80-539

[8] Banerjee AK(2016)Use and misuse of common terminology criteria for adverse events in cancer clinical trials BMC Cancer 16 392-3676

[9] Okun S(2012)Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology Journal of Clinical Oncology 30 4249-285

[10] Edwards IR(2007)Clinically relevant fatigue in cancer outpatients: The Edinburgh Cancer Centre symptom study Annals of Oncology 18 1861-418

[1] Basch E(2010)The missing patient voice in drug-safety reporting New England Journal of Medicine 362 865-317

[2] Basch E(2014)New frontiers in patient-reported outcomes: Adverse event reporting, comparative effectiveness, and quality assessment Annual Review of Medicine 65 307-1149

[3] Ebile AW(2015)Assessing the detection, reporting and investigation of adverse events in clinical trial protocols implemented in Cameroon: A documentary review of clinical trial protocols BMC Medical Ethics 16 67-196

[4] Ateudjieu J(2013)Patient-reported outcome measures in safety event reporting: PROSPER Consortium guidance Drug Safe 36 1129-87

[5] Yakum MN(2014)Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) Journal of the National Cancer Institute 106 dju244-4255

[6] Djuidje MN(1977)The measurement of observer agreement for categorical data Biometrics 33 189-1052

[7] Watcho P(2016)A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department International Journal of Clinical Pharmacy 38 80-539

[8] Banerjee AK(2016)Use and misuse of common terminology criteria for adverse events in cancer clinical trials BMC Cancer 16 392-3676

[9] Okun S(2012)Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology Journal of Clinical Oncology 30 4249-285

[10] Edwards IR(2007)Clinically relevant fatigue in cancer outpatients: The Edinburgh Cancer Centre symptom study Annals of Oncology 18 1861-418